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Does Prophylactic Administration of TXA Reduce Mean Operative Time and Postoperative Blood Loss
in Posterior Approach Lumbar Spinal Fusion Surgery Performed for Degenerative Spinal Disease?
Evan Larson, Emmett Gannon, Tyler Evans, Jake Long, Elizabeth Lyden, Chris Cornett

Mentor: Chris Cornett
Program: Orthopaedic Surgery
Objective: To investigate association between
prophylactic TXA administration prior to
one and two-level posterior lumbar interbody
fusion operations and perioperative blood
loss, mean operative time, postoperative
transfusion, and postoperative venous
thromboembolic events.
Summary of Background Data: Tranexamic
acid (TXA) is a systemic anti-fibrinolytic that
competitively inhibits lysine binding sites on
plasminogen, reversibly blocking its binding
to fibrin and impeding fibrinolysis and clot
degradation. TXA’s role in routine spinal

surgery remains poorly described. Most spinal
literature on perioperative TXA administration
has considered operations performed for
major adult and pediatric spinal deformity.
Methods: Two groups, a study group
composed of 75 patients who underwent one
and two-level posterior lumbar interbody
fusion operations for degenerative indications
who received TXA prior to the start of the
procedure, and a control group composed of
75 patients who underwent similar surgeries
for the same indications and did not receive
TXA preoperatively, were retrospectively
enrolled. Demographic, laboratory, and
surgical data were collected and analyzed.

Results: Statistically significant reductions
were noted in the TXA group in postoperative
day 1 drain output (p < 0.0041), total
postoperative drain output (p = 0.027), and
mean surgical time (p < 0.0001).
Conclusions: Based on the results of the
current study, we feel TXA’s routine use
should be considered in one and two- level
posterior lumbar fusion operations performed
for degenerative indications, as it is safe to
administer routinely and associated with
reduced postoperative drain output and mean
surgical time. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.036
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Background & Objectives: Opioid pain
medications prescriptions following upper
extremity surgery is part of the standard of
care. However, there is a growing concern
about opioid abuse, overdose deaths, and
diversion of opioids in the community. New
evidence suggesting opioid overprescription
has prompted a closer look at current practice.
Objectives of this quality improvement
project are 1) to define prescribing habits and
patient utilization of opioids following upper
extremity surgery within our institution, 2)
to develop prescription guidelines, and 3)
to educate patients about opioid usage and
disposal.

Methods: Stage I consists of collecting
prospective data from patients undergoing
upper extremity surgery by 4 upper extremity
surgeons over 6 consecutive months. Data
are gathered from the electronic medical
record and survey at clinic visits up to 90
days postoperatively including level of pain,
opioid pills prescribed (converted to morphine
equivalents), number of unused pills, and date
of last opioid use. Patients are asked whether
they were educated on pill disposal. Results
will be used to develop prescription guidelines
and patient education protocols.

prescriptions guided by previous results will
be provided with standardized education on
opioid disposal. The aforementioned data will
again be collected at clinic visits up to 90 days
postoperatively. Data from each stage will
then be compared to assess the effectiveness
of the implemented guidelines.
Results & Conclusions: Pending further data
collection. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.037

Stage II consists of collecting prospective data
from patients undergoing upper extremity
surgery by 4 upper extremity surgeons over
6 consecutive months. Postoperative opioid
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Background & Objectives: Opioid pain
medications prescribed following total hip
arthroplasty (THA) and total knee arthroplasty
(TKA) are critical to postoperative pain
management. However, a lack of evidence
regarding appropriate prescription practices
can contribute to overprescribing and
diversion of opioids within the community.
Objectives of this quality improvement project
are 1) to understand prescribing habits and
patient utilization of opioids following THA
47

and TKA within our institution, 2) develop
appropriate prescription guidelines, and 3)
improve patient knowledge regarding unused
opioid disposal.
Methods: Stage I consists of collecting
prospective data from opioid-naïve patients
undergoing primary THA and TKA over 6
consecutive months. Data are gathered from
the electronic medical record and survey at
clinic visits up to 90 days postoperatively
including level of pain, number/type of opioid
pills prescribed postoperatively (converted
to morphine equivalents), number of unused
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pills, and date of last opioid use. Patients are
asked whether they were educated on disposal
of unused opioids. Results will be used to
develop opioid prescription guidelines and
patient education protocols which will be
implemented during Stage II.
Stage II consists of collecting prospective
data from opioid-naïve patients undergoing
primary THA and TKA over 6 consecutive
months. Postoperative opioid prescriptions
guided by previous results will be provided
with standardized education on opioid
disposal. The aforementioned data will again

Graduate Medical Education Research Journal

